EP3537453A1 — Hand held communication device
Assigned to Bayer AG · Expires 2019-09-11 · 7y expired
What this patent protects
The present invention relates to a hand held communication device. It is described to provide (310) information relating to a patient to a hand held communication device. A communication link is established (320) between the hand held communication device and an apparatus associa…
USPTO Abstract
The present invention relates to a hand held communication device. It is described to provide (310) information relating to a patient to a hand held communication device. A communication link is established (320) between the hand held communication device and an apparatus associated with the patient comprising utilization of the information relating to the patient. The hand held communication device receives (330) operational data associated with operation of a medical device by the patient. Receiving the operational data involves receiving (332) compliance data over the communication link from the apparatus relating to utilization of the medical device for a medical condition of the patient.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.